Adaptive Biotechnologies Corp

Maps immune genetics for blood cancer diagnostics and drug discovery partnerships.

ADPT | NDAQ

Overview

Corporate Details

ISIN(s):: US00650F1093
LEI:
Country:: United States of America
Address:: 1165 EASTLAKE AVE E, 98109 SEATTLE
Website:: https://www.adaptivebiotech.com
Sector:: Mining and quarrying
Industry:: Mining of non-ferrous metal ores

Description

Adaptive Biotechnologies is a commercial-stage biotechnology company pioneering the field of immune medicine. The company's proprietary Immune Medicine Platform maps the genetics of the adaptive immune system by sequencing T-cell and B-cell receptors at scale. This technology enables two primary application areas: clinical diagnostics and drug discovery. Its key diagnostic product is a highly sensitive, next-generation sequencing (NGS)-based assay for the assessment of Minimal Residual Disease (MRD) in blood cancers, used in both clinical practice and drug trials. Additionally, Adaptive partners with pharmaceutical companies, providing rich immune receptor data and services to inform clinical trials and support the development of new therapeutics.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Adaptive Biotechnologies Corp filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Adaptive Biotechnologies Corp

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for Adaptive Biotechnologies Corp via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
Eezy Oyj HR services firm for the full employment lifecycle, from recruitment to freelancer support.	Finland	EEZY
Elicio Therapeutics, Inc. Develops lymph node-targeted immunotherapies for aggressive, KRAS-driven cancers.	United States of America	ELTX
enCore Energy Corp. American uranium producer using ISR technology to fuel the U.S. nuclear energy sector.	United States of America	EU
ENERGY FUELS INC A leading U.S. producer of uranium and rare earth elements for EVs, defense, and technology.	United States of America	UUUU
ENIGMATIG LTD Global expansion and regulatory compliance consultancy for the financial services industry.	United States of America	EGG
Enjin Co., Ltd. PR firm for SMEs and medical institutions, offering consulting and a media matching platform.	Japan	7370
Ensol Biosciences Inc. Develops AI-discovered peptide drugs for cancer, osteoarthritis, and Alzheimer's disease.	South Korea	140610
Enveric Biosciences, Inc. Develops novel neuroplastogen drugs for severe mental health and addiction disorders.	United States of America	ENVB
Eutilex Co.,Ltd. Develops T-cell and antibody immunotherapies for cancer and autoimmune diseases.	South Korea	263050
Evaxion A/S Develops AI-powered, personalized vaccines for cancer and infectious diseases.	United States of America	EVAX